Stay updated on Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changes from v3.8.0 to v3.8.1; the study record content appears unchanged.
    Difference
    0.0%
    Check dated 2026-11-17T17:10:27.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed SUNNIFORECAST study is displayed with its trial design, eligibility criteria, study locations, outcome measures, investigators, and related publications.
    Difference
    67%
    Check dated 2026-11-10T16:14:18.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T16:44:26.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology changes was added above the ClinicalTrials.gov page, and the site revision changed from v3.7.1 to v3.7.2. The page content still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-20T19:08:58.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:50:39.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simple header and Home link, replacing the previous study record details and related navigation.
    Difference
    19%
    Check dated 2026-09-22T20:59:30.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.